On April 21, 2021, The US Food and Drug Administration (FDA) issued guidance detailing its approach to remote interactive evaluations of drug and biomedical research facilities during the public health emergency. Teleconferencing, livestreaming video and screen-sharing technologies are among the tools FDA says it will use when it determines that a remote interactive evaluation is appropriate for a particular facility.

Download the guidance here.